Back to mobile site

Citi Reiterates Buy Rating on Emerson (EMR)

November 5, 2024 8:22 AM EST Send to a Friend
Citi analyst Andrew Kaplowitz reiterated a Buy rating and $128.00 price target on Emerson (NYSE: EMR).The analyst comments "EMR reported ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login